Source:http://linkedlifedata.com/resource/pubmed/id/17878335
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-9-19
|
pubmed:abstractText |
The frequency of circulating alloreactive human memory T cells correlates with allograft rejection. Memory T cells may be divided into effector memory (T(EM)) and central memory (T(CM)) cell subsets, but their specific roles in allograft rejection are unknown. We report that CD4+ T(EM) (CD45RO+ CCR7- CD62L-) can be adoptively transferred readily into C.B-17 SCID/bg mice and mediate the destruction of human endothelial cells (EC) in vascularized human skin grafts allogeneic to the T cell donor. In contrast, CD4+ T(CM) (CD45RO+ CCR7+ CD62L+) are inefficiently transferred and do not mediate EC injury. In vitro, CD4+ T(EM) secrete more IFN-gamma within 48 h in response to allogeneic ECs than do T(CM). In contrast, T(EM) and T(CM) secrete comparable amounts of IFN-gamma in response to allogeneic monocytes (Mo). In the same cultures, both T(EM) and T(CM) produce IL-2 and proliferate in response to IFN-gamma-treated allogeneic human EC or Mo, but T(CM) respond more vigorously in both assays. Blockade of LFA-3 strongly inhibits both IL-2 and IFN-gamma secretion by CD4+ T(EM) cultured with allogeneic EC but only minimally inhibits responses to allogeneic Mo. Blockade of CD80 and CD86 strongly inhibits IL-2 but not IFN-gamma production by in response to allogeneic EC or Mo. Transduction of EC to express B7-2 enhances allogeneic T(EM) production of IL-2 but not IFN-gamma. We conclude that human CD4+ T(EM) directly recognize and respond to allogeneic EC in vitro by secreting IFN-gamma and that this response depends on CD2 but not CD28. Consistent with EC activation of effector functions, human CD4+ T(EM) can mediate allogeneic EC injury in vivo.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
179
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4397-404
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17878335-Animals,
pubmed-meshheading:17878335-Antigen-Presenting Cells,
pubmed-meshheading:17878335-Antigens, CD58,
pubmed-meshheading:17878335-Antigens, CD80,
pubmed-meshheading:17878335-CD4-Positive T-Lymphocytes,
pubmed-meshheading:17878335-Cells, Cultured,
pubmed-meshheading:17878335-Endothelial Cells,
pubmed-meshheading:17878335-Female,
pubmed-meshheading:17878335-Humans,
pubmed-meshheading:17878335-Immunologic Memory,
pubmed-meshheading:17878335-Interferon-gamma,
pubmed-meshheading:17878335-Interleukin-2,
pubmed-meshheading:17878335-Mice,
pubmed-meshheading:17878335-Mice, SCID
|
pubmed:year |
2007
|
pubmed:articleTitle |
Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo.
|
pubmed:affiliation |
Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.
|
pubmed:publicationType |
Journal Article
|